Merger and acquisition news has been a bit light of late, but there is at least one deal out there this Monday for M&A watchers to chew over. MEDTOX Scientific, Inc. (NASDAQ: MTOX) has entered into a definitive merger agreement with Laboratory Corporation of America Holdings (NYSE: LH).
LabCorp will be acquiring MEDTOX in a premium buyout that values the company at a share price not seen since briefly in 2007. The purchase price is at $27.00 per share and the merger is an all cash deal. It will also give MEDTOX A total enterprise value of approximately $241,000,000 after considering equity and debt.
MEDTOX is a provider of high quality specialized lab testing services and on-site/point-of-collection testing devices. The board of directors of MEDTOX unanimously approved the agreement and recommended approval of the transaction by MEDTOX’s shareholders.
Shares are up 35% at $26.71 for MEDTOX versus a prior 52-week trading range of $11.64 to $22.55; Laboratory Corp. of America Holdings (NYSE: LH) shares are up 0.9% at $83.07 against a 52-week range of $74.57 to $99.76. As far as how the value compares, LabCorp has a market value of some $8 billion.
JON C. OGG
Cash Back Credit Cards Have Never Been This Good
Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
